These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 2095035)
21. Treatment of ocular tissues exposed to nitrogen mustard: beneficial effect of zinc desferrioxamine combined with steroids. Morad Y; Banin E; Averbukh E; Berenshtein E; Obolensky A; Chevion M Invest Ophthalmol Vis Sci; 2005 May; 46(5):1640-6. PubMed ID: 15851563 [TBL] [Abstract][Full Text] [Related]
22. Topical treatments for hydrofluoric acid dermal burns. Further assessment of efficacy using an experimental piq model. Dunn BJ; MacKinnon MA; Knowlden NF; Billmaier DJ; Derelanko MJ; Rusch GM; Naas DJ; Dahlgren RR J Occup Environ Med; 1996 May; 38(5):507-14. PubMed ID: 8733642 [TBL] [Abstract][Full Text] [Related]
23. [Animal experiment and clinical studies of the use of anti-inflammatory agents in chemical burns of the eye]. Struck HG; Franke C; Tost M; Taube C Klin Monbl Augenheilkd; 1988 Oct; 193(4):401-6. PubMed ID: 3236744 [TBL] [Abstract][Full Text] [Related]
24. Ocular burn: rinsing and healing with ionic marine solutions and vegetable oils. Said T; Dutot M; Labbé A; Warnet JM; Rat P Ophthalmologica; 2009; 223(1):52-9. PubMed ID: 19023222 [TBL] [Abstract][Full Text] [Related]
25. [Necrolytic properties of alkaline protease in the treatment of severe eye burns]. Chalanova RI Vestn Oftalmol; 2003; 119(2):36-8. PubMed ID: 13678008 [TBL] [Abstract][Full Text] [Related]
26. The beneficial effects of doxycycline, an inhibitor of matrix metalloproteinases, on sulfur mustard-induced ocular pathologies depend on the injury stage. Horwitz V; Dachir S; Cohen M; Gutman H; Cohen L; Fishbine E; Brandeis R; Turetz J; Amir A; Gore A; Kadar T Curr Eye Res; 2014 Aug; 39(8):803-12. PubMed ID: 24502433 [TBL] [Abstract][Full Text] [Related]
27. Comparison of topical magnesium and calcium treatment for dermal hydrofluoric acid burns. Burkhart KK; Brent J; Kirk MA; Baker DC; Kulig KW Ann Emerg Med; 1994 Jul; 24(1):9-13. PubMed ID: 8010555 [TBL] [Abstract][Full Text] [Related]
28. Studies on the treatment of hydrofluoric acid burn. Murao M Bull Osaka Med Coll; 1989 Nov; 35(1-2):39-48. PubMed ID: 2486242 [TBL] [Abstract][Full Text] [Related]
29. Is it time for a change in the approach to chemical burns? The role of Diphoterine Lewis CJ; Al-Mousawi A; Jha A; Allison KP J Plast Reconstr Aesthet Surg; 2017 May; 70(5):563-567. PubMed ID: 28330646 [TBL] [Abstract][Full Text] [Related]
30. RGTA-based matrix therapy in severe experimental corneal lesions: safety and efficacy studies. Brignole-Baudouin F; Warnet JM; Barritault D; Baudouin C J Fr Ophtalmol; 2013 Nov; 36(9):740-7. PubMed ID: 23958066 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of intravenous magnesium sulfate for the treatment of hydrofluoric acid burns. Cox RD; Osgood KA J Toxicol Clin Toxicol; 1994; 32(2):123-36. PubMed ID: 8145352 [TBL] [Abstract][Full Text] [Related]
32. An improved method for emergent decontamination of ocular and dermal hydrofluoric acid splashes. Soderberg K; Kuusinen P; Mathieu L; Hall AH Vet Hum Toxicol; 2004 Aug; 46(4):216-8. PubMed ID: 15303400 [TBL] [Abstract][Full Text] [Related]
33. The safety and efficacy of Diphoterine for ocular and cutaneous burns in humans. Lynn DD; Zukin LM; Dellavalle R Cutan Ocul Toxicol; 2017 Jun; 36(2):185-192. PubMed ID: 27486965 [TBL] [Abstract][Full Text] [Related]
34. Effects of dimethyl sulfoxide on a model of corneal alkali injury. Skrypuch OW; Tokarewicz AC; Willis NR Can J Ophthalmol; 1987 Feb; 22(1):17-20. PubMed ID: 3815150 [TBL] [Abstract][Full Text] [Related]
36. Alkali ocular burns in Martinique (French West Indies) Evaluation of the use of an amphoteric solution as the rinsing product. Merle H; Donnio A; Ayeboua L; Michel F; Thomas F; Ketterle J; Leonard C; Josset P; Gerard M Burns; 2005 Mar; 31(2):205-11. PubMed ID: 15683694 [TBL] [Abstract][Full Text] [Related]
37. [Use of lavage fluid containing diphoterine for irrigation of eyes in first aid emergency treatment]. Langefeld S; Press UP; Frentz M; Kompa S; Schrage N Ophthalmologe; 2003 Sep; 100(9):727-31. PubMed ID: 14504898 [TBL] [Abstract][Full Text] [Related]
38. Emergency treatment of eye burns: which rinsing solution should we choose? Rihawi S; Frentz M; Schrage NF Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):845-54. PubMed ID: 16365735 [TBL] [Abstract][Full Text] [Related]
39. [Specific features of the pathogenesis of epichlorohydrin eye burns and their treatment (an experimental clinico-morphological study)]. Khoroshilova IP; Ilatovskaia LV; Bordiugova GG; Gakhramanov FS Vestn Oftalmol; 1991; 107(1):12-6. PubMed ID: 1709763 [TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of topical infliximab in a mouse model of ocular surface scarring. Ferrari G; Bignami F; Giacomini C; Franchini S; Rama P Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1680-8. PubMed ID: 23404121 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]